Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer

Published on Feb 1, 2014in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2014.01.007
Matthew H. Stenmark16
Estimated H-index: 16
(UM: University of Michigan),
Anna Conlon13
Estimated H-index: 13
(UM: University of Michigan)
+ 10 AuthorsDaniel A. Hamstra39
Estimated H-index: 39
(UM: University of Michigan)
Sources
Abstract
Abstract Purpose To evaluate rectal dose and post-treatment patient-reported bowel quality of life (QOL) following radiation therapy for prostate cancer. Methods Patient-reported QOL was measured at baseline and 2-years via the expanded prostate cancer index composite (EPIC) for 90 patients. Linear regression modeling was performed using the baseline score for the QUANTEC normal tissue complication probability model and dose volume histogram (DVH) parameters for the whole and segmented rectum (superior, middle, and inferior). Results At 2-years the mean summary score declined from a baseline of 96.0–91.8. The median volume of rectum treated to ⩾70 Gy (V70) was 11.7% for the whole rectum and 7.0%, 24.4%, and 1.3% for the inferior, middle, and superior rectum, respectively. Mean dose to the whole and inferior rectum correlated with declines in bowel QOL while dose to the mid and superior rectum did not. Low (V25–V40), intermediate (V50–V60) and high (V70–V80) doses to the inferior rectum influenced bleeding, incontinence, urgency, and overall bowel problems. Only the highest dose (V80) to the mid-rectum correlated with rectal bleeding and overall bowel problems. Conclusions Segmental DVH analysis of the rectum reveals associations between bowel QOL and inferior rectal dose that could significantly influence radiation planning and prognostic models.
📖 Papers frequently viewed together
525 Citations
227 Citations
46 Citations
References33
Newest
#1Daniel A. Hamstra (UM: University of Michigan)H-Index: 39
#2Anna Conlon (UM: University of Michigan)H-Index: 13
Last. Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 73
view all 13 authors...
Purpose To evaluate patients treated with external beam radiation therapy as part of the multicenter Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment (PROSTQA), to identify factors associated with posttreatment patient-reported bowel health-related quality of life (HRQOL). Methods and Materials Pretreatment characteristics and treatment details among 292 men were evaluated using a general linear mixed model for their association with measured HRQOL by the Expanded Pros...
32 CitationsSource
#1Daniel A. Hamstra (UM: University of Michigan)H-Index: 39
#2Matt H. Stenmark (UM: University of Michigan)H-Index: 1
Last. Felix Y. Feng (UM: University of Michigan)H-Index: 78
view all 14 authors...
Purpose To assess the impacts of patient age and comorbid illness on rectal toxicity following external beam radiation therapy (EBRT) for prostate cancer and to assess the Qualitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) normal tissue complication probability (NTCP) model in this context. Methods and Materials Rectal toxicity was analyzed in 718 men previously treated for prostate cancer with EBRT (≥75 Gy). Comorbid illness was scored using the Charlson Comorbidity Index (CC...
30 CitationsSource
#1Eric Yeoh (University of Adelaide)H-Index: 19
#2Richard H. Holloway (University of Adelaide)H-Index: 15
Last. Julie Butters (Royal Adelaide Hospital)H-Index: 5
view all 6 authors...
Purpose To characterize the prevalence, pathophysiology, and natural history of chronic radiation proctitis 5 years following radiation therapy (RT) for localized carcinoma of the prostate. Methods and Materials Studies were performed in 34 patients (median age 68 years; range 54-79) previously randomly assigned to either 64 Gy in 32 fractions over 6.4 weeks or 55 Gy in 20 fractions over 4 weeks RT schedule using 2- and later 3-dimensional treatment technique for localized prostate carcinoma. Ea...
25 CitationsSource
#1J.M. Michalski (WashU: Washington University in St. Louis)H-Index: 14
#1Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 73
Last. H.M. SandlerH-Index: 5
view all 10 authors...
Purpose/Objective(s): To report the long-term survival and toxicity outcomes with the use of ultra-high-dose intensity modulated radiation therapy (IMRT) to a dose of 86.4 Gy for patients with localized prostate cancer. Materials/Methods: Between August 1997 and December 2008, 1002 patients were treated to a dose of 86.4 Gy using a 5-7 field IMRT technique. Patients were stratified into prognostic risk groups based on the National Comprehensive Cancer Network risk-grouping system. Five hundred e...
3 CitationsSource
#1Susan L. Tucker (University of Texas MD Anderson Cancer Center)H-Index: 90
#2Lei Dong (University of Texas MD Anderson Cancer Center)H-Index: 73
Last. Radhe Mohan (University of Texas MD Anderson Cancer Center)H-Index: 115
view all 8 authors...
Purpose To investigate whether the volumes of rectum exposed to intermediate doses, from 30 to 50 Gy, contribute to the risk of Grade ≥2 late rectal toxicity among patients with prostate cancer receiving radiotherapy. Methods and Materials Data from 1009 patients treated on Radiation Therapy Oncology Group protocol 94-06 were analyzed using three approaches. First, the contribution of intermediate doses to a previously published fit of the Lyman-Kutcher-Burman (LKB) normal tissue complication pr...
27 CitationsSource
#2H. Joseph Barthold (Harvard University)H-Index: 1
#3Elizabeth O'Meara (Radiation Therapy Oncology Group)H-Index: 8
Last. Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 20
view all 21 authors...
Purpose To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials. Methods and Materials One male pelvis computed tomography (CT) data set and one female pelvis CT data set were shared via the Image-Guided Therapy QA Center. A total of 16 radiation oncologists participated. The following organs at risk were contoured in both CT sets: anus, anorectum, rectum (gastrointestinal and genitourinary definitions), bowel NOS (not otherwise specif...
266 CitationsSource
#1Florian BuettnerH-Index: 27
#2Sarah L. GullifordH-Index: 23
Last. Mike PartridgeH-Index: 38
view all 6 authors...
Abstract Purpose Most studies investigating the dose–response of the rectum focus on rectal bleeding. However, it has been reported that other symptoms such as urgency or sphincter control have a large impact on quality-of-life and that different symptoms are related to the dose to different parts of the anorectal wall. In this study correlations between the 3D dose distribution to the anal-sphincter region and radiation-induced side-effects were quantified. Materials and methods Dose–surface ma...
46 CitationsSource
#1Paul L. Nguyen (Harvard University)H-Index: 68
#2Ronald C. Chen (Harvard University)H-Index: 9
Last. James A. Talcott (Harvard University)H-Index: 40
view all 9 authors...
Purpose We examined whether rectal dose–volume histogram (DVH) parameters were associated with long-term patient-reported gastrointestinal (GI) quality of life (QOL) after conventional (70.2 GyE) or high-dose (79.2 GyE) radiation for prostate cancer. Methods and Materials Of 64 men with localized prostate cancer alive with a minimum 7-year follow-up after treatment as part of a randomized trial with either 70.2 GyE or 79.2 GyE of external beam radiation at Massachusetts General Hospital, 56 men ...
32 CitationsSource
#1Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 20
#3Andrew Jackson (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 59
Last. Joseph O. Deasy (WashU: Washington University in St. Louis)H-Index: 63
view all 4 authors...
The available dose/volume/outcome data for rectal injury were reviewed. The volume of rectum receiving ≥60Gy is consistently associated with the risk of Grade ≥2 rectal toxicity or rectal bleeding. Parameters for the Lyman-Kutcher-Burman normal tissue complication probability model from four clinical series are remarkably consistent, suggesting that high doses are predominant in determining the risk of toxicity. The best overall estimates (95% confidence interval) of the Lyman-Kutcher-Burman mod...
525 CitationsSource
#1Sarah L. Gulliford (National Health Service)H-Index: 23
#2K. Foo (Wollongong Hospital)H-Index: 9
Last. David P. DearnaleyH-Index: 108
view all 15 authors...
Purpose: Radical radiotherapy for prostate cancer is effective but dose limited because of the proximity of normal tissues. Comprehensive dose–volume analysis of the incidence of clinically relevant late rectal toxicities could indicate how the dose to the rectum should be constrained. Previous emphasis has been on constraining the mid-to-high dose range ($50 Gy). Evidence is emerging that lower doses could also be important. Methods and Materials: Data from a large multicenter randomized trial ...
109 CitationsSource
Cited By34
Newest
#1Gabriella F. Bulman (Mayo Clinic)
#2R.S. Bhangoo (Mayo Clinic)H-Index: 3
Last. Steven E. Schild (Mayo Clinic)H-Index: 81
view all 11 authors...
Source
#1Martin A. Ebert (SCGH: Sir Charles Gairdner Hospital)H-Index: 26
#2Sarah L. Gulliford (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 23
Last. Claudio Fiorino (UniSR: Vita-Salute San Raffaele University)H-Index: 54
view all 10 authors...
For decades, dose-volume information for segmented anatomy has provided the essential data for correlating radiotherapy dosimetry with treatment-induced complications. Dose-volume information has formed the basis for modelling those associations via normal tissue complication (NTCP) models and for driving treatment planning. Limitations to this approach have been identified. Many studies have emerged demonstrating that the incorporation of information describing the spatial nature of the dose di...
Source
#1Douglas Brand (ICR: Institute of Cancer Research)H-Index: 5
#2Sarah C. Brüningk (ETH Zurich)
Last. Sarah L. Gulliford (UCL: University College London)H-Index: 23
view all 12 authors...
Abstract Purpose Changes in fraction size of external beam radiotherapy (EBRT) exert non-linear impacts on subsequent toxicity. Commonly described by the linear-quadratic model, fraction size sensitivity of normal tissues is expressed by the α/β ratio. Here we study individual α/β ratios for different late rectal side effects after prostate EBRT. Methods and Materials The XXXXXXX trial (XX-REGISTRATION-NUMBER-XX) randomised men with non-metastatic prostate cancer 1:1:1 to 74Gy/37 fractions (Fr),...
2 CitationsSource
#1Thomas Quinn (Beaumont Hospital)H-Index: 36
#1Thomas J. Quinn (Beaumont Hospital)H-Index: 2
Last. Daniel A. Hamstra (Beaumont Hospital)H-Index: 6
view all 24 authors...
Abstract Purpose/Objective(s) Previously a phase III trial of a hydrogel rectal spacer during prostate RT found decreased toxicity and a clinically significant improvement in bowel quality of life (QOL) at 3-years by Expanded Prostate Cancer Index (EPIC). We performed a secondary analysis to identify men less likely to benefit. Materials/Methods Clinical and dosimetric data for the 222 patients enrolled on the *** trial were analyzed. The volume of rectum treated to 70 Gy (V70) as well as the QU...
4 CitationsSource
#1D. Reijtenbagh (EUR: Erasmus University Rotterdam)H-Index: 1
#2Jeremy Godart (EUR: Erasmus University Rotterdam)H-Index: 3
Last. Mischa S. Hoogeman (EUR: Erasmus University Rotterdam)H-Index: 48
view all 6 authors...
Abstract Background and purpose To investigate relationships between patient-reported acute gastro-intestinal symptoms in a locally advanced cervical cancer (LACC) prospective cohort and clinical and dosimetric parameters, while also taking spatial dose into account. Material and methods A total of 103 patients was included, receiving radiotherapy based on a plan-library-based plan-of-the-day protocol, combined either with concurrent chemotherapy or with neo-adjuvant chemotherapy and concomitant...
1 CitationsSource
#1Anna Wilkins (The Royal Marsden NHS Foundation Trust)H-Index: 11
#2O. Naismith (The Royal Marsden NHS Foundation Trust)H-Index: 10
Last. Sarah L. GullifordH-Index: 23
view all 7 authors...
Abstract Background The CHHiP trial randomised 3216 men with localised prostate cancer (1:1:1) to three radiotherapy fractionation schedules: 74Gy/37 fractions (f) over 7.4 weeks, 60Gy/20f/4 weeks and 57Gy/19f/3.8 weeks. Literature-based dose constraints were applied with arithmetic adjustment for the hypofractionated arms. This study aimed to derive anorectal dose constraints using prospectively-collected clinician-reported outcomes (CRO) and patient-reported outcomes (PRO) and to assess the ad...
12 CitationsSource
#1Anouk J. M. Rombouts (Radboud University Nijmegen)H-Index: 8
#2Niek Hugen (Radboud University Nijmegen)H-Index: 14
Last. Johannes H. W. de Wilt (Radboud University Nijmegen)H-Index: 50
view all 6 authors...
Abstract Background The aim of this study was to analyse the association between pelvic radiation therapy (RT) and the development of rectal cancer as a second primary cancer. Methods Data on patients treated for a primary pelvic cancer between 1989 and 2007 were retrieved from the population-based Netherlands Cancer Registry. Patients treated for more than one pelvic cancer were excluded. To estimate the cumulative incidence of rectal cancer, Fine and Gray's competing risk model was used with d...
5 CitationsSource
#1Oscar Casares-Magaz (Aarhus University Hospital)H-Index: 8
#2Steffen Bülow (Aarhus University Hospital)H-Index: 1
Last. Ludvig Paul Muren (Aarhus University Hospital)H-Index: 31
view all 10 authors...
State-of-the-art radiotherapy (RT) for prostate cancer has led to improved overall cancer-specific survival rates by increasing the dose delivered to the target, while maintaining the doses deliver...
7 CitationsSource
#1Caroline Olsson (University of Gothenburg)H-Index: 12
#2Andrew Jackson (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 59
Last. Maria Thor (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 16
view all 4 authors...
Purpose The aims of this study were to systematically review tolerance doses for late distinct gastrointestinal (GI), genitourinary (GU), and sexual dysfunction (SD) symptoms after external beam radiation therapy (EBRT) alone and treatments involving brachytherapy (BT) for prostate cancer after Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) and ultimately to perform quantitative syntheses of identified dose/volume tolerances represented by dose-volume histogram (DVH) thre...
23 CitationsSource
#1Michael Trager (Thomas Jefferson University Hospital)H-Index: 1
#2Benjamin A. Greenberger (Thomas Jefferson University Hospital)H-Index: 6
Last. Robert B. Den (Thomas Jefferson University Hospital)H-Index: 42
view all 5 authors...
High-dose-rate (HDR) brachytherapy is an attractive option for patients receiving definitive radiation therapy for prostate cancer with decreased overall dose to the pelvis. However, ulcerative colitis increases rectal toxicity risk and may be a contraindication. A synthetic hydrogel, SpaceOAR (Augmentix Inc., Waltham, MA, USA), can facilitate the use of HDR brachytherapy for patients where rectal toxicity is a limiting factor. SpaceOAR gel (13.19 cc) was utilized in a monotherapy HDR prostate t...
2 CitationsSource